Vortioxetine
Back to searchMolecule Structure
Scientific Name
Vortioxetine
Description of the Drug
Vortioxetine is a serotonin modulating antidepressant indicated for the treatment of major depressive disorder (MDD).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09068
http://www.drugbank.ca/drugs/DB09068
Brand Name(s)
Brintellix
Company Owner(s)
Zydus Pharmaceuticals Usa Inc, Takeda Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Serotonin 3a (5-HT3a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1899 |
| Serotonin 1a (5-HT1a) receptor | SINGLE PROTEIN | AGONIST | CHEMBL214 |
| Serotonin transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL228 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL236115 | ||
| PharmGKB | PA166122595 | ||
| Human Metabolome Database | HMDB0259875 | ||
| DrugBank | DB09068 | ||
| PubChem: Thomson Pharma | 14942974 | ||
| PubChem | 9966051 | ||
| LINCS | LSM-45585 | ||
| Nikkaji | J3.095.728H | ||
| BindingDB | 50400902 | ||
| DrugCentral | 4806 | ||
| ChemicalBook | CB62614395 | ||
| Guide to Pharmacology | 7351 | ||
| rxnorm | TRINTELLIX | VORTIOXETINE | VORTIOXETINE HYDROBROMIDE |
| ChEBI | 76016 | ||
| ZINC | ZINC000034051848 |
